|
|
Article: STAAR Surgical Collamer[R] Accommodating Study Team Reports First Phase Assessments at AAO.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products reported that the Collamer Accommodating Study Team (CAST) formed by the company in late 2008 has provided very promising initial patient vision assessments from the first phase of the project. The CAST is comprised of eight prominent cataract/refractive surgeons from across the United States who since June 2009 have implanted more than 300 eyes with the STAAR nanoFLEX intraocular lens (IOL) for the treatment of cataracts (see also Presbyopia).
The purpose of the CAST first phase is to evaluate the accommodating properties of the current ...